Mesoblast (MESO) Cash & Equivalents (QoQ) (2017 - 2023)
Mesoblast (MESO) Cash & Equivalents (QoQ) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Mesoblast | 18.89 Bn | 18.76 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 46.15% |
| Mar 31, 2023 | -27.83% |
| Dec 31, 2022 | -20.92% |
| Sep 30, 2022 | 41.45% |
| Jun 30, 2022 | -21.25% |
| Mar 31, 2022 | -19.07% |
| Dec 31, 2021 | -18.20% |
| Sep 30, 2021 | -15.29% |
| Jun 30, 2021 | -13.51% |
| Mar 31, 2021 | 104.14% |
| Dec 31, 2020 | -28.30% |
| Sep 30, 2020 | -16.40% |
| Jun 30, 2020 | 115.27% |
| Mar 31, 2020 | -26.15% |
| Dec 31, 2019 | 135.55% |
| Sep 30, 2019 | -31.51% |
| Jun 30, 2019 | -28.36% |
| Mar 31, 2019 | -8.62% |
| Dec 31, 2018 | 39.68% |
| Sep 30, 2018 | 46.02% |